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The origin of fetal sterols in second-trimester amniotic fluid:
endogenous synthesis or maternal-fetal transport?
Maria E. Baardman, MD; Jan Jaap H. M. Erwich, MD, PhD; Rolf M. F. Berger, MD, PhD; Robert M. W. Hofstra, PhD;
Wilhelmina S. Kerstjens-Frederikse, MD; Dieter Lütjohann, PhD; Torsten Plösch, PhDt
i
tOBJECTIVE: Cholesterol is crucial for fetal development. To gain more
insight into the origin of the fetal cholesterol pool in early human preg-
nancy, we determined cholesterol and its precursors in the amniotic
fluid of uncomplicated, singleton human pregnancies.
STUDY DESIGN: Total sterols were characterized by gas chromatogra-
hy–mass spectrometry in the second-trimester amniotic fluid of 126
ealthy fetuses from week 15 until week 22.
RESULTS: The markers of cholesterol biosynthesis, lanosterol, dihy-
drolanosterol, and lathosterol, were present in low levels until the 19th-sitos-
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Serol, a marker for maternal-fetal cholesterol transport, was detectable
n the amniotic fluid. The total cholesterol levels increased slightly be-
ween weeks 15 and 22.
CONCLUSION: Our results support the hypothesis that during early life
the fetus depends on maternal cholesterol supply because endogenous
synthesis is relatively low. Therefore, maternal cholesterol can play a
crucial role in fetal development.
Key words: cholesterol biosynthesis, embryology, maternal-fetal
cholesterol transportweek of gestation, after which their levels increased strongly.
Cite this article as: Baardman ME, Erwich JJHM, Berger RMF, et al. The origin of fetal sterols in second-trimester amniotic fluid: endogenous synthesis orCholesterol is the most importantsterol in humans. Its role in mem-
rane fluidity and as a precursor of bile
cids and steroid hormones has beendis-
ussed extensively. In addition to these
mportant functions in adult mammals,
holesterol is also crucial for embryonic
evelopment. It activates the sonic hedge-
og (Shh) proteins and propagates their
ignaling: after beingmodified by addition
f cholesterol. Shh sets off a cascade of
vents in target cells, leading to the activa-
ion and repression of genes by transcrip-
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eed throughout embryonic and fetal
evelopment.2
Although fetal tissues synthesize cho-
lesterol, we and others have shown that
maternal cholesterol also contributes
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EPTEMBER 2012 Americansubstantially to the fetal cholesterol pool
in animal models.3-6 However, only a
few studies have addressed this in hu-
mans. Vuorio et al7 discovered that, just
after birth, plant sterol concentrations in
cord blood of healthy newbornswere 40-
50%of thematernal levels, indicative for
active maternal-fetal sterol transport.
Furthermore, a specific maternal lipid
profile, resulting in a more rapid mater-
nal-fetal cholesterol transport, tends to
result in a milder phenotype of Smith-
Lemli-Opitz syndrome (SLOS), a disor-
der of cholesterol biosynthesis.8 This
suggests that the maternal cholesterol
supply is of great importance during
early life and that disturbances in lipid
transport can have adverse effects on the
fetal development.
Before uteroplacental circulations are
established, maternal-fetal nutrient ex-
change of high-molecular-weight mole-
cules (eg, proteins and lipids) takes place
through the yolk sac, which is connected
to the ventral part of the embryo and the
main blood circulation through the vi-
telline veins. Molecules from themother
leak easily into the exocoelomic cavity
because of the loose mesenchymal layer
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Research Basic Science: Obstetrics www.AJOG.orginto the fetal circulation.10Various sterol
ransporter proteins are expressed on
oth the yolk sac and the early placenta,
uggesting active transport of these mol-
cules to fetal tissues.3,11,12 The yolk sac
n humans regresses around week 8 of
estationwhen the placenta takes over its
ole in nutrient exchange.
In addition to active transport by the
itelline veins, the amniotic fluid (AF)
urrounding the embryo may also play
n important role in maternal-fetal nu-
rient exchange.13 Several lipoprotein re-
eptors and enzymes involved in lipo-
rotein uptake, such as the low-density
ipoprotein receptor and lipoprotein
ipase, are found on the apical surface of
he amniotic membrane at term, sug-
esting that lipoproteins from the amni-
tic fluid or maternal circulation are
aken up by the amnion and could there-
ore serve as a transporter for fetal lip-
ds.14 From animal studies we know that
changes in maternal diet directly influ-
ence the AF composition.15 However,
because most of the AF consists of fetal
bioproducts,16 the AF seems to be an in-
terestingmedium to studywith regard to
the origin of fetal sterols.
Despite the important roles of choles-
terol in fetal development and of mater-
nal-fetal cholesterol transport, the origin
of the fetal cholesterol pool in the first
half of a human pregnancy is still un-
clear. This is mainly because of the obvi-
ously limited accessibility of the human
fetus for transport studies. Because um-
bilical functions are not routinely per-
formed in prenatal diagnosis, the amni-
otic fluid surrounding the fetus can be
used as an alternative medium for mea-
suring endogenous synthesis and mater-
nal-fetal cholesterol transport. Amniotic
fluid samples are readily available from
amniocentesis samples. However, the
few human studies that are performed to
analyze the concentration of different
sterols inAF are small in sample sizewith
fewer than 100 cases and detailed infor-
mation about the sterol concentrations
related to gestational age is lacking.17
While we were analyzing our data,
Amaral et al18 published apaper inwhich
hey reportedmeasurements of different
terol precursors inAF.Our study signif-
cantly adds to their data, which is fur-
202.e20 American Journal of Obstetrics& Gynecoher explained in the Comment section
f the article.
In this study, we used sterol concen-
rations in amniotic fluid as markers for
etal sterol turnover. The cholesterol pre-
ursors, lanosterol, dihydrolanosterol, la-
hosterol, and desmosterol, are all impor-
ant biochemical markers of cholesterol
iosynthesis. We analyzed these sterols to
eterminetherelativecholesterol synthesis
ates in the second trimester of human
regnancies. Furthermore, we determined
-sitosterol levels in AF, one of the most
important plant sterols. Because humans
are not capable of synthesizing plant ste-
rols and because plant sterols are trans-
ported in a similar way to cholesterol, we
assumed this would be a valid marker
to measure maternal-fetal cholesterol
transport.
Because cholesterol is of crucial im-
portance for heart development through
its role in Shh signaling, we analyzed
concentrations of cholesterol and its pre-
cursors, together with plant sterols in the
AF of pregnancies complicated by iso-
lated fetal congenital heart anomalies to
test our hypothesis that maternal-fetal
cholesterol transport is important for
providing the cholesterol needed for
proper fetal development.
We had 2 aims: first, to investigate the
origin of the fetal cholesterol pool in sec-
ond-trimester amniotic fluid of healthy
pregnancies (is it derived from synthesis
[represented by increased precursor lev-
els] or from maternal-fetal transport
[represented by increased -sitosterol
evels])? Second, because cholesterol is
specially important for fetal heart de-
elopment, we compared the levels of
ifferent sterols and their precursors in
regnancies with an isolated fetal heart
efect with the levels in pregnancies





We retrospectively selected AF samples
from 126 singleton pregnancies with a
normal birth outcome in 2003 until 2010
at the University Medical Center Gro-
ningen. Amniocentesis was performed n
logy SEPTEMBER 2012mainly if there was an increased risk for
aneuploidy because of a positive prenatal
screening or because of increasedmater-
nal age.
Directly after amniocentesis the AF
samples were stored at 20°C. Women
were asked whether surplus fluid, not
needed for diagnosis, could be used for
research. This conforms with the hospi-
tal code of good practice for surplus ma-
terial of the Dutch Consortium of Scien-
tific Associations. Ethics approval was
given by the University Medical Center
Groningen Ethics Committee.
Information on birth outcome (with
informed consent) was available for all
pregnancies and obtained from hospital
records, fromEurocat NorthernNether-
lands (a population-based birth defects
registry that covers 80% of the university’s
hospital population) and from popula-
tion-based perinatal registration records.
Samples were organized according to ges-
tational age from week 15 until week 22.
Numbers for each week of gestational age
were as follows: week 15, n 14; week 16,
n 20; week 17, n 41; week 18, n 18;
eek 19, n 7; week 20, n 11; to week
1, n  9; to week 22, n  6. Unfortu-
ately, we could notmake groups of equal
ize for each week because we selected the
amples retrospectively.
ample group 2
e retrospectively selected AF of 40 sin-
leton pregnancies that were compli-
ated by a congenital heart anomaly of
he fetus, which was diagnosed prena-
ally and confirmed after birth. Cases
ithmultiple congenital anomalies were
xcluded. Because amniocentesis was
erformed after the diagnosis of congen-
tal heart anomalies by prenatal ultra-
ound scan (routinely performed in The
etherlands around week 20 of gesta-
ion), we could include samples only
rom gestational week 19 until week 23.
roups were too small to divide the
eart anomalies into different cardiac
ubgroups.
ample group 3
e selected additional control samples
f children and fetuses prenatally diag-


















www.AJOG.org Basic Science: Obstetrics Researchteogenesis imperfecta, a skeletal disorder
that is not related to cholesterol distur-
bances in themother or the child. All the
cases werematched to 1 control from the
same gestational week. If there was more
than 1 control, they were pooled.
Sample group 4
Three fresh AF samples were obtained
from women at 16 weeks of gestation
who underwent amniocentesis for in-
creased risk of aneuploidy because of in-
creasedmaternal age. These were used to
evaluate cholesterol fractions in cells and
free fluid after centrifuging for 10 min-
utes at 2000 rpmwithout freezer storage.
Reagents, standards, and
sample preparation
Twenty-five microliters of cholestane
(milligrams per milliliter) and 10 L of
epicoprostanol were added as internal
standards to 500 L of AF samples. Al-
aline hydrolysis was performed adding
.5 mL 10% ethanolic NAOH (1M) fol-
owed by heating at 60°C for 60minutes.
he samples were diluted with 0.5 mL of
eionized water, and the lipids were ex-
racted with 3 mL of cyclohexane. The
ipids were derivatized by adding 50 L
f n-decane and 10 L of trimethylsilyl
ether at 70°C for 60 minutes and analyzed
by gas chromatography–mass spectrome-
try (GC-MS)according to themethodsde-
scribed by Thelen et al.19
Statistical analysis
Statistical analysis was performed using
SPSS software (version 18.0 for Win-
TABLE 1
Sterol concentrations in 126 amnio
Variable
Week 15 Week 16
(n  14) (n  20)
Cholesterol 54.30  16.51 53.90  16.9
...................................................................................................................
Lanosterol 0.010  0.003 0.009  0.0
...................................................................................................................
Dihydrolanosterol 0.002  0.001 0.002  0.0
...................................................................................................................
Lathosterol 0.117  0.049 0.095  0.0
...................................................................................................................
Desmosterol 0.450  0.156 0.447  0.2
...................................................................................................................
-sitosterol 0.165  0.088 0.140  0.0
...................................................................................................................
Concentrations (mol/L) of cholesterol, lathosterol, sitosterol, d
15 to 22.
Baardman. The origin of fetal sterols in second-trimester adows; SPSS Inc, Chicago, IL). Spear-man’s correlation test was used to com-
pare sterol distributions as well as to
evaluate the correlation of the parame-
ters gestational age and sterol concentra-
tions.Weused theMann-WhitneyU test
o compare sterol distributions between
ases and controls for each gestational
ge and in total.
RESULTS
Sterol concentrations in normal
pregnancies
Our data for sterol levels in the AF of 126
healthy fetuses followed a nonlinear dis-
tribution. Concentrations for each sterol
at each gestational week (with 95% con-
fidence intervals) are shown in Table 1.
The total cholesterol levels were slightly
increased between week 15 and 22 (Fig-
ure 1), although therewas a veryhighvari-
ation between 16.3 and 140.5mol/L.
Figure 1 shows the correlations be-
tween the different sterol precursors and
gestational age.
A strong, statistically significant correla-
tion between dihydrolanosterol and la-
thosterol concentrations with gestational
age was obtained with a correlation coeffi-
cientclose to1(P .001).Thesesterolpre-
cursors were detectable in very low levels
until the 19th week of gestation, after
which their levels increased strongly. For
lanosterol we found a moderately positive
correlation, showing the same pattern as
dihydrolanosterol and lathosterol (Figure
1). -sitosterol was detectable in signifi-
cantamounts inAFandvaried throughout
the second trimester of pregnancy (Figure
fluid samples of healthy fetuses
Week 17 Week 18 Week 19
(n  41) (n  18) (n  7)
51.30  14.34 56.84  13.24 74.15  26.02
.........................................................................................................................
0.004  0.002 0.008  0.004 0.019  0.015
.........................................................................................................................
0.003  0.002 0.008  0.004 0.016  0.016
.........................................................................................................................
0.136  0.065 0.222  0.095 0.528  0.446
.........................................................................................................................
0.476  0.141 0.532  0.118 0.569  0.250
.........................................................................................................................
0.084  0.024 0.091  0.025 0.173  0.075
.........................................................................................................................
osterol, dihydrolanosterol, and lanosterol were determined in 126 a
iotic fluid. Am J Obstet Gynecol 2012.1). The same patternwas also observed for t
SEPTEMBER 2012 Americandesmosterol (Figure 1) and for other rele-
vant plant sterols and stanols (campes-
terol, stigmasterol and cholestanol) (data
not shown).
Desmosterol and-sitosterol were both
strongly correlated with total cholesterol
levels (data not shown). For the sterol pre-
cursors lanosterol, dihydrolanosterol, and
lathosterol, we found positive moderate
correlations with total cholesterol concen-
trations. After correcting for total choles-
terol concentration, dihydrolanosterol
and lathosterol levels remained strongly
correlated with gestational age; whereas,
lanosterol remained moderate positively
correlated with gestational age. Desmos-
terol and-sitosterol showedamoderately
negative correlationafter correcting for to-
tal cholesterol (P .001) (Table 2).
Sterol concentrations in congenital
heart disease
We compared sterol concentrations in
AF of fetuses with confirmed nonsyn-
dromic congenital heart disease and age-
matched controls (Figure 2). Lanosterol
levels were significantly lower in the
cases than in controls in weeks 21-22
(P  .013; P  .04). Concentrations for
-sitosterol were significantly lower in
cases than in controls between weeks 19
and 20 (P .038; P .016). We did not
nd any statistically significant differ-
nces between cases and controls for di-
ydrolanosterol, lathosterol, or desmos-
erol (levels equally distributed in both
ases and controls) or for total choles-
Week 20 Week 21 Week 22
(n  11) (n  9) (n  6)
66.62  25.19 79.60  36.51 66.05  36.22
..................................................................................................................
0.105  0.192 0.133  0.104 0.103  0.027
..................................................................................................................
0.021  0.009 0.055  0.036 0.071  0.033
..................................................................................................................
0.890  0.442 1.958  1.482 1.689  0.267
..................................................................................................................
0.418  0.139 0.461  0.255 0.423  0.179
..................................................................................................................
0.110  0.058 0.220  0.115 0.097  0.023
..................................................................................................................
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We analyzed different sterols and their
precursors in second-trimester human
AF to investigate the origin of fetal cho-
FIGURE 1
Correlation between sterols and ge
Spearman correlation coefficients are shown for each
Baardman. The origin of fetal sterols in second-trimester amn
TABLE 2
Correlation between the







Lanosterol 0.33  .001
...........................................................................................................
Dihydrolanosterol 0.81  .001
...........................................................................................................






Correlation between the cholesterol ratios of different
sterol precursors and gestational age in second-tri-
mester amniotic fluid of 126 healthy fetuses after cor-
rection for cholesterol concentrations.
Baardman. The origin of fetal sterols in second-
trimester amniotic fluid. Am J Obstet Gynecol 2012.
202.e22 American Journal of Obstetrics& Gynecolesterol. We found a significant increase
of the cholesterol precursors lanosterol,
dihydrolanosterol, and lathosterol from
gestational week 19 onward, indicating
increasing fetal synthesis from that mo-
ment in time. Our results suggest that
during early life the fetus depends on
maternal cholesterol as an exogenous
source.
Amniotic fluid is a part of the fetal com-
partment, and therefore, lipids found in
theAFbelongto the fetalpool.Becausehu-
man fetal tissues of uncomplicated preg-
nancies are not readily available, we pro-
pose here that amniotic fluid is a valuable
alternative for studies on early cholesterol
synthesis and maternal-fetal cholesterol
transport.
There are 2 pathways of cholesterol
synthesis in humans. One is the Bloch
pathway via zymosterol and desmos-
terol, and the other is the Kandutsch-
Russell pathway through lathosterol and
7-dehydrocholesterol.20 Previous stud-
tional age
h. Asterisks and circles show outliers and extreme va
c fluid. Am J Obstet Gynecol 2012.ies have shown that the first is active in
logy SEPTEMBER 2012tissue of humanbrains betweenweeks 10
and 20 of gestation.However, the 2 stud-
ies that report this are very small in num-
bers and show contrary results.21,22 Be-
cause the few patients (n  7) that are
describedwith desmosterolosis, an auto-
somal recessive disorder caused by mu-
tations in genes that code for proteins in-
volved in the final step of the Bloch
pathway, mainly show brain anoma-
lies,23 the role of desmosterol in the de-
velopment of other organ systems is still
under debate.
Our data showed that levels of des-
mosterol remained constant compared
with the raised levels of the sterol precur-
sors from the Kandutsch-Russell path-
way. The almost constant total choles-
terol concentrations, together with the
increased sterol precursor concentra-
tions, suggest an increased fetal choles-
terol synthesis rate from week 19 on-
ward. Thus, our data suggest that, in the
first half of pregnancy, exogenous (ma-
, which were excluded in our calculations.sta





















www.AJOG.org Basic Science: Obstetrics Researchfulfill the fetal demands, whereas from
week 19 onward, fetal cholesterol syn-
thesis via the Kandutsch-Russell path-
way becomes increasingly important.
One limitation of our study is that, be-
cause of the retrospective study design,
we could not measure maternal choles-
terol concentrations in plasma and there-
fore could not calculate the maternal
plasma to amniotic fluid ratio of total
cholesterol.
Plant sterols are transported via mem-
branes in a comparable way with choles-
terol and are here used asmarkers forma-
ternally derived cholesterol because their
only source is thematernal diet.We found
that-sitosterol and other plant sterols re-
ained constant throughout the second
rimester of pregnancy, which indicates
hat the fetusmainly uses cholesterol from
he mother for its cholesterol needs and
remature biosynthesis.
Recently Amaral et al18 published a pa-
per in which they reported measurements
FIGURE 2
Sterol concentrations in congenita
Statistically significant P values of the Mann-Whit
xcluded in our calculations. There were no d
Mann-Whitney U test).
Baardman. The origin of fetal sterols in second-trimester amnof different sterol precursors in AF. Theyreported that levels of total cholesterol and
its precursors, lathosterol, desmosterol,
and 7-dehydrocholesterol, increase as ges-
tation progresses. We could confirm their
data only on lathosterol concentrations.
7-Dehydrocholesterol was not detectable
in our samples. They concluded that fetal
cholesterol synthesis increases from week
19 onward; however, this conclusion was
based on absolute increased precursor lev-
els only.
In contrast, we gained support for our
hypothesis for an increased level of cho-
lesterol synthesis on augmented ratios of
precursor to cholesterol levels (Table 2).
Measurements of absolute levels of ste-
rols in AF are insufficient because of re-
ported variations in the consistency of
the fluid (ie, more diluted or more
concentrated).24
Our study also adds new data on
lanosterol and dihydrolanosterol levels
in amniotic fluid showing the same in-
crease in concentration as gestation pro-
art disease
U test are shown in the graphs. Asterisks and cir
rences in total distribution of sterols accordin
c fluid. Am J Obstet Gynecol 2012.gresses and supporting the data on la-
SEPTEMBER 2012 Americanthosterol. One important difference
between our study and that of Amaral et
al18 is that they analyzed cell-free AF,
hereas we used complete AF samples.
e found that the cell fraction accounts
or about 25% of total sterols (data not
hown).
Cells in the AF can be categorized into
different cell types: epitheloid type cells
E-type), amniotic fluid-specific type
ells (AF-type), and fibroblastic type
ells (F-type). The E-type cells are de-
ived from fetal skin and urine, the AF-
ype from fetalmembranes andplacental
rophoblasts, and the F-type from con-
ective and mesenchymal tissues and
ermal fibroblasts.17,25
These studies underline the impor-
tance of analyzing the complete AF sam-
ple as cholesterol and sterol precursors
are detectable in all 3 cell types and there-
fore contribute significantly to the fetal
cholesterol pool.
In children with SLOS, a disorder of
display outliers and extreme values, which were
gestational age between cases and controlsl he
ney cles
iffe g to
ioticholesterol biosynthesis, a lack of choles-
Journal of Obstetrics& Gynecology 202.e23
Research Basic Science: Obstetrics www.AJOG.orgterol in utero disturbs Shh signaling, re-
sulting in various heart anomalies. We
hypothesized that the same mechanism
might play a role in nonsyndromic heart
defects. To test this, we investigated dif-
ferences in sterol concentrations in the
amniotic fluid of childrenwith andwith-
out a congenital heart anomaly. We did
not find any consistent significant differ-
ences between cases and controls, indi-
cating that sterol metabolism is not in-
volved in themajority of cases of congenital
heart anomalies. However, based on our
data, itcannotbeexcludedthatsomecasesof
congenital heart anomalies are related to
transport deficits (measuredby-sitosterol)
and others to insufficient synthesis (repre-
sented by lanosterol) or even by a combina-
tion of those two.
Our sample size was not large enough
to focus on relevant subgroups reported
to be influenced by cholesterol and Shh,
like atrioventricular septal defects, te-
tralogy of Fallot, atrial septal defects,
outflow tract anomalies such as persis-
tent truncus arteriosus, and anomalies of
the pulmonary veins.26-31 We encourage
other researchers to investigate total
cholesterol and its precursors in the am-
niotic fluid of children with cholesterol-
and Shh-related heart defects without a
diagnosis of SLOS, ideally in a multi-
center study.
Our study provides new insights into
the origin of fetal cholesterol in early
pregnancy and new information on the
sterol precursors lanosterol and dihy-
drolanosterol. Our results suggest that,
during early life, the fetus depends on
maternal cholesterol as an exogenous
cholesterol source because the endoge-
nous synthesis through the Kandutsch-
Russell pathway is not yet established.
Maternal cholesterol could therefore
play a crucial role in fetal development
because cholesterol drives important de-
velopmental signaling pathways.
This information is particularly im-
portant because maternal conditions
and diseases that disturb cholesterol
concentrations (ie, obesity and diabetes)
are increasing rapidly among pregnant
women. Although we could not find any
differences in the AF of fetuses with and
without a congenital heart anomaly in
the gestational period studied, the avail-
202.e24 American Journal of Obstetrics& Gynecoability of maternal cholesterol very early
in embryogenesis might still be an im-
portant factor in fetal heart develop-
ment. Future research should now focus
on maternal-fetal cholesterol transport
in the first trimester of pregnancy during
embryogenesis. f
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